Computational Medicine and Drug Discovery Software Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Medicine and Drug Discovery Software Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Database
1.2.3 Software
1.2.4 Others
1.3 Market by Application
1.3.1 Global Computational Medicine and Drug Discovery Software Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Computational Physiological Medicine
1.3.3 Drug Discovery And Development
1.3.4 Medical Imaging
1.3.5 Disease Modeling
1.3.6 Predictive Analysis Of Drug Targets
1.3.7 Cellular Simulation
1.3.8 Simulation Software
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Computational Medicine and Drug Discovery Software Market Perspective (2018-2030)
2.2 Computational Medicine and Drug Discovery Software Growth Trends by Region
2.2.1 Computational Medicine and Drug Discovery Software Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Computational Medicine and Drug Discovery Software Historic Market Size by Region (2018-2023)
2.2.3 Computational Medicine and Drug Discovery Software Forecasted Market Size by Region (2023-2030)
2.3 Computational Medicine and Drug Discovery Software Market Dynamics
2.3.1 Computational Medicine and Drug Discovery Software Industry Trends
2.3.2 Computational Medicine and Drug Discovery Software Market Drivers
2.3.3 Computational Medicine and Drug Discovery Software Market Challenges
2.3.4 Computational Medicine and Drug Discovery Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computational Medicine and Drug Discovery Software Players by Revenue
3.1.1 Global Top Computational Medicine and Drug Discovery Software Players by Revenue (2018-2023)
3.1.2 Global Computational Medicine and Drug Discovery Software Revenue Market Share by Players (2018-2023)
3.2 Global Computational Medicine and Drug Discovery Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computational Medicine and Drug Discovery Software Revenue
3.4 Global Computational Medicine and Drug Discovery Software Market Concentration Ratio
3.4.1 Global Computational Medicine and Drug Discovery Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Medicine and Drug Discovery Software Revenue in 2022
3.5 Computational Medicine and Drug Discovery Software Key Players Head office and Area Served
3.6 Key Players Computational Medicine and Drug Discovery Software Product Solution and Service
3.7 Date of Enter into Computational Medicine and Drug Discovery Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Medicine and Drug Discovery Software Breakdown Data by Type
4.1 Global Computational Medicine and Drug Discovery Software Historic Market Size by Type (2018-2023)
4.2 Global Computational Medicine and Drug Discovery Software Forecasted Market Size by Type (2023-2030)
5 Computational Medicine and Drug Discovery Software Breakdown Data by Application
5.1 Global Computational Medicine and Drug Discovery Software Historic Market Size by Application (2018-2023)
5.2 Global Computational Medicine and Drug Discovery Software Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Computational Medicine and Drug Discovery Software Market Size (2018-2030)
6.2 North America Computational Medicine and Drug Discovery Software Market Size by Country (2018-2023)
6.3 North America Computational Medicine and Drug Discovery Software Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Computational Medicine and Drug Discovery Software Market Size (2018-2030)
7.2 Europe Computational Medicine and Drug Discovery Software Market Size by Country (2018-2023)
7.3 Europe Computational Medicine and Drug Discovery Software Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computational Medicine and Drug Discovery Software Market Size (2018-2030)
8.2 Asia-Pacific Computational Medicine and Drug Discovery Software Market Size by Country (2018-2023)
8.3 Asia-Pacific Computational Medicine and Drug Discovery Software Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Computational Medicine and Drug Discovery Software Market Size (2018-2030)
9.2 Latin America Computational Medicine and Drug Discovery Software Market Size by Country (2018-2023)
9.3 Latin America Computational Medicine and Drug Discovery Software Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computational Medicine and Drug Discovery Software Market Size (2018-2030)
10.2 Middle East & Africa Computational Medicine and Drug Discovery Software Market Size by Country (2018-2023)
10.3 Middle East & Africa Computational Medicine and Drug Discovery Software Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Entelos
11.1.1 Entelos Company Detail
11.1.2 Entelos Business Overview
11.1.3 Entelos Computational Medicine and Drug Discovery Software Introduction
11.1.4 Entelos Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023)
11.1.5 Entelos Recent Development
11.2 Genedata
11.2.1 Genedata Company Detail
11.2.2 Genedata Business Overview
11.2.3 Genedata Computational Medicine and Drug Discovery Software Introduction
11.2.4 Genedata Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023)
11.2.5 Genedata Recent Development
11.3 Crown Bioscience
11.3.1 Crown Bioscience Company Detail
11.3.2 Crown Bioscience Business Overview
11.3.3 Crown Bioscience Computational Medicine and Drug Discovery Software Introduction
11.3.4 Crown Bioscience Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023)
11.3.5 Crown Bioscience Recent Development
11.4 Biognos
11.4.1 Biognos Company Detail
11.4.2 Biognos Business Overview
11.4.3 Biognos Computational Medicine and Drug Discovery Software Introduction
11.4.4 Biognos Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023)
11.4.5 Biognos Recent Development
11.5 Chemical Computing Group
11.5.1 Chemical Computing Group Company Detail
11.5.2 Chemical Computing Group Business Overview
11.5.3 Chemical Computing Group Computational Medicine and Drug Discovery Software Introduction
11.5.4 Chemical Computing Group Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023)
11.5.5 Chemical Computing Group Recent Development
11.6 Leadscope
11.6.1 Leadscope Company Detail
11.6.2 Leadscope Business Overview
11.6.3 Leadscope Computational Medicine and Drug Discovery Software Introduction
11.6.4 Leadscope Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023)
11.6.5 Leadscope Recent Development
11.7 Nimbus Therapeutics
11.7.1 Nimbus Therapeutics Company Detail
11.7.2 Nimbus Therapeutics Business Overview
11.7.3 Nimbus Therapeutics Computational Medicine and Drug Discovery Software Introduction
11.7.4 Nimbus Therapeutics Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023)
11.7.5 Nimbus Therapeutics Recent Development
11.8 Rhenovia Pharma Limited
11.8.1 Rhenovia Pharma Limited Company Detail
11.8.2 Rhenovia Pharma Limited Business Overview
11.8.3 Rhenovia Pharma Limited Computational Medicine and Drug Discovery Software Introduction
11.8.4 Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023)
11.8.5 Rhenovia Pharma Limited Recent Development
11.9 Schrodinger
11.9.1 Schrodinger Company Detail
11.9.2 Schrodinger Business Overview
11.9.3 Schrodinger Computational Medicine and Drug Discovery Software Introduction
11.9.4 Schrodinger Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023)
11.9.5 Schrodinger Recent Development
11.10 Compugen
11.10.1 Compugen Company Detail
11.10.2 Compugen Business Overview
11.10.3 Compugen Computational Medicine and Drug Discovery Software Introduction
11.10.4 Compugen Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023)
11.10.5 Compugen Recent Development
11.11 Dassault Systemes
11.11.1 Dassault Systemes Company Detail
11.11.2 Dassault Systemes Business Overview
11.11.3 Dassault Systemes Computational Medicine and Drug Discovery Software Introduction
11.11.4 Dassault Systemes Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023)
11.11.5 Dassault Systemes Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Computational Medicine and Drug Discovery Software Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2030
Table 2. Key Players of Database
Table 3. Key Players of Software
Table 4. Key Players of Others
Table 5. Global Computational Medicine and Drug Discovery Software Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2030
Table 6. Global Computational Medicine and Drug Discovery Software Market Size by Region (US$ Million): 2018 VS 2022 VS 2030
Table 7. Global Computational Medicine and Drug Discovery Software Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Computational Medicine and Drug Discovery Software Market Share by Region (2018-2023)
Table 9. Global Computational Medicine and Drug Discovery Software Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 10. Global Computational Medicine and Drug Discovery Software Market Share by Region (2023-2030)
Table 11. Computational Medicine and Drug Discovery Software Market Trends
Table 12. Computational Medicine and Drug Discovery Software Market Drivers
Table 13. Computational Medicine and Drug Discovery Software Market Challenges
Table 14. Computational Medicine and Drug Discovery Software Market Restraints
Table 15. Global Computational Medicine and Drug Discovery Software Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Computational Medicine and Drug Discovery Software Market Share by Players (2018-2023)
Table 17. Global Top Computational Medicine and Drug Discovery Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Discovery Software as of 2022)
Table 18. Ranking of Global Top Computational Medicine and Drug Discovery Software Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Computational Medicine and Drug Discovery Software Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Computational Medicine and Drug Discovery Software Product Solution and Service
Table 22. Date of Enter into Computational Medicine and Drug Discovery Software Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Computational Medicine and Drug Discovery Software Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Computational Medicine and Drug Discovery Software Revenue Market Share by Type (2018-2023)
Table 26. Global Computational Medicine and Drug Discovery Software Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 27. Global Computational Medicine and Drug Discovery Software Revenue Market Share by Type (2023-2030)
Table 28. Global Computational Medicine and Drug Discovery Software Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Computational Medicine and Drug Discovery Software Revenue Market Share by Application (2018-2023)
Table 30. Global Computational Medicine and Drug Discovery Software Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 31. Global Computational Medicine and Drug Discovery Software Revenue Market Share by Application (2023-2030)
Table 32. North America Computational Medicine and Drug Discovery Software Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Computational Medicine and Drug Discovery Software Market Size by Country (2023-2030) & (US$ Million)
Table 34. Europe Computational Medicine and Drug Discovery Software Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Computational Medicine and Drug Discovery Software Market Size by Country (2023-2030) & (US$ Million)
Table 36. Asia-Pacific Computational Medicine and Drug Discovery Software Market Size by Region (2018-2023) & (US$ Million)
Table 37. Asia-Pacific Computational Medicine and Drug Discovery Software Market Size by Region (2023-2030) & (US$ Million)
Table 38. Latin America Computational Medicine and Drug Discovery Software Market Size by Country (2018-2023) & (US$ Million)
Table 39. Latin America Computational Medicine and Drug Discovery Software Market Size by Country (2023-2030) & (US$ Million)
Table 40. Middle East & Africa Computational Medicine and Drug Discovery Software Market Size by Country (2018-2023) & (US$ Million)
Table 41. Middle East & Africa Computational Medicine and Drug Discovery Software Market Size by Country (2023-2030) & (US$ Million)
Table 42. Entelos Company Detail
Table 43. Entelos Business Overview
Table 44. Entelos Computational Medicine and Drug Discovery Software Product
Table 45. Entelos Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023) & (US$ Million)
Table 46. Entelos Recent Development
Table 47. Genedata Company Detail
Table 48. Genedata Business Overview
Table 49. Genedata Computational Medicine and Drug Discovery Software Product
Table 50. Genedata Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023) & (US$ Million)
Table 51. Genedata Recent Development
Table 52. Crown Bioscience Company Detail
Table 53. Crown Bioscience Business Overview
Table 54. Crown Bioscience Computational Medicine and Drug Discovery Software Product
Table 55. Crown Bioscience Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023) & (US$ Million)
Table 56. Crown Bioscience Recent Development
Table 57. Biognos Company Detail
Table 58. Biognos Business Overview
Table 59. Biognos Computational Medicine and Drug Discovery Software Product
Table 60. Biognos Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023) & (US$ Million)
Table 61. Biognos Recent Development
Table 62. Chemical Computing Group Company Detail
Table 63. Chemical Computing Group Business Overview
Table 64. Chemical Computing Group Computational Medicine and Drug Discovery Software Product
Table 65. Chemical Computing Group Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023) & (US$ Million)
Table 66. Chemical Computing Group Recent Development
Table 67. Leadscope Company Detail
Table 68. Leadscope Business Overview
Table 69. Leadscope Computational Medicine and Drug Discovery Software Product
Table 70. Leadscope Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023) & (US$ Million)
Table 71. Leadscope Recent Development
Table 72. Nimbus Therapeutics Company Detail
Table 73. Nimbus Therapeutics Business Overview
Table 74. Nimbus Therapeutics Computational Medicine and Drug Discovery Software Product
Table 75. Nimbus Therapeutics Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023) & (US$ Million)
Table 76. Nimbus Therapeutics Recent Development
Table 77. Rhenovia Pharma Limited Company Detail
Table 78. Rhenovia Pharma Limited Business Overview
Table 79. Rhenovia Pharma Limited Computational Medicine and Drug Discovery Software Product
Table 80. Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023) & (US$ Million)
Table 81. Rhenovia Pharma Limited Recent Development
Table 82. Schrodinger Company Detail
Table 83. Schrodinger Business Overview
Table 84. Schrodinger Computational Medicine and Drug Discovery Software Product
Table 85. Schrodinger Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023) & (US$ Million)
Table 86. Schrodinger Recent Development
Table 87. Compugen Company Detail
Table 88. Compugen Business Overview
Table 89. Compugen Computational Medicine and Drug Discovery Software Product
Table 90. Compugen Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023) & (US$ Million)
Table 91. Compugen Recent Development
Table 92. Dassault Systemes Company Detail
Table 93. Dassault Systemes Business Overview
Table 94. Dassault Systemes Computational Medicine and Drug Discovery SoftwareProduct
Table 95. Dassault Systemes Revenue in Computational Medicine and Drug Discovery Software Business (2018-2023) & (US$ Million)
Table 96. Dassault Systemes Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Computational Medicine and Drug Discovery Software Market Share by Type: 2022 VS 2030
Figure 2. Database Features
Figure 3. Software Features
Figure 4. Others Features
Figure 5. Global Computational Medicine and Drug Discovery Software Market Share by Application in 2022 & 2030
Figure 6. Computational Physiological Medicine Case Studies
Figure 7. Drug Discovery And Development Case Studies
Figure 8. Medical Imaging Case Studies
Figure 9. Disease Modeling Case Studies
Figure 10. Predictive Analysis Of Drug Targets Case Studies
Figure 11. Cellular Simulation Case Studies
Figure 12. Simulation Software Case Studies
Figure 13. Computational Medicine and Drug Discovery Software Report Years Considered
Figure 14. Global Computational Medicine and Drug Discovery Software Market Size (US$ Million), Year-over-Year: 2018-2030
Figure 15. Global Computational Medicine and Drug Discovery Software Market Size, (US$ Million), 2018 VS 2022 VS 2030
Figure 16. Global Computational Medicine and Drug Discovery Software Market Share by Region: 2022 VS 2030
Figure 17. Global Computational Medicine and Drug Discovery Software Market Share by Players in 2022
Figure 18. Global Top Computational Medicine and Drug Discovery Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Discovery Software as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Computational Medicine and Drug Discovery Software Revenue in 2022
Figure 20. North America Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 21. North America Computational Medicine and Drug Discovery Software Market Share by Country (2018-2030)
Figure 22. United States Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 23. Canada Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 24. Europe Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 25. Europe Computational Medicine and Drug Discovery Software Market Share by Country (2018-2030)
Figure 26. Germany Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 27. France Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 28. U.K. Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 29. Italy Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 30. Russia Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 31. Nordic Countries Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 32. Asia-Pacific Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 33. Asia-Pacific Computational Medicine and Drug Discovery Software Market Share by Region (2018-2030)
Figure 34. China Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 35. Japan Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 36. South Korea Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 37. Southeast Asia Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 38. India Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 39. Australia Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 40. Latin America Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 41. Latin America Computational Medicine and Drug Discovery Software Market Share by Country (2018-2030)
Figure 42. Mexico Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 43. Brazil Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 44. Middle East & Africa Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 45. Middle East & Africa Computational Medicine and Drug Discovery Software Market Share by Country (2018-2030)
Figure 46. Turkey Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 47. Saudi Arabia Computational Medicine and Drug Discovery Software Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 48. Entelos Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2018-2023)
Figure 49. Genedata Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2018-2023)
Figure 50. Crown Bioscience Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2018-2023)
Figure 51. Biognos Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2018-2023)
Figure 52. Chemical Computing Group Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2018-2023)
Figure 53. Leadscope Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2018-2023)
Figure 54. Nimbus Therapeutics Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2018-2023)
Figure 55. Rhenovia Pharma Limited Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2018-2023)
Figure 56. Schrodinger Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2018-2023)
Figure 57. Compugen Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2018-2023)
Figure 58. Dassault Systemes Revenue Growth Rate in Computational Medicine and Drug Discovery Software Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed